Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MA › Holyoke › NPI 1104007913
Physician

Harvey, Lisa

Harvey, Lisa was paid $51K by Medicaid between May 2018 and Jul 2019, across 4 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 45% of everything it billed.

33Billing provider infoHARVEY, LISA
HOLYOKE, MA 01040
33aNPI1104007913assigned 11/20/2007
28Total paid$51K
24GClaims859
24DCodes billed4
24AFirst – last monthMay 2018 – Jul 2019
Compared with peers

Next to other General Practice Physician providers in Massachusetts

Rank by total paid#22 of 33
Median peer was paid$76K
This provider vs. median0.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$5.0K$10K$15K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018296$14K
2019563$37K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 45% 485 288 $23K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 45% 273 133 $23K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 10% 86 80 $5K
80076 <1% 15 15 $126.45

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.